𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Symptom-to-Diagnosis Interval and Survival in Cancers of the Digestive Tract

✍ Scribed by Esteve Fernandez; Miquel Porta; Núria Malats; Josep Belloc; Manuel Gallén

Book ID
110396611
Publisher
Springer US
Year
2002
Tongue
English
Weight
66 KB
Volume
47
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of the p53 gene in relation to
Analysis of the p53 gene in relation to tobacco and alcohol in cancers of the upper aero-digestive tract
✍ S. Franceschi; A. Gloghini; R. Maestro; L. Barzan; E. Bidoli; R. Talamini; T. Vu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 585 KB

To elucidate the relationship, if any, of p53 gene expression according to smoking and drinking habits, 135 subjects with cancer of the upper aero-digestive tract were sampled from a case-control investigation conducted in Pordenone province, Northeast Italy, between 1986 and I99 I. Adequate patholo

Association of polymorphisms in the cycl
Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract
✍ Shama Buch; Bing Zhu; Autumn Gaither Davis; Dominic Odom; Jill M. Siegfried; Jen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract DNA repair enzyme genetic polymorphisms have been postulated to increase the risk of certain cancers in the presence of tobacco carcinogen exposures. The XPD protein is an important component of the TFIIH transcription factor complex. __XPD__ genetic polymorphisms resulting in amino aci

Aberrant FHIT transcripts in cancerous a
Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract
✍ Yi-Jen Chen; Pao-Huei Chen; Meng-Dar Lee; Jan-Gowth Chang 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 119 KB 👁 2 views

The FHIT gene was recently discovered and proposed as a tumor-suppressor gene. We examined the FHIT gene in a panel of digestive-tract cancers along with their corresponding non-tumorous tissues by reverse transcription of FHIT mRNA followed by PCR amplification and sequencing of the products. A nor